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Background: Plant viruses cause many serious plant diseases and are currently suppressed with the simultaneous
use of virucides and insecticides. The use of such materials, however, increases the amounts of pollutants in the
environment. To reduce environmental contaminants, virucides with insecticidal activity is an attractive option.
Results: A series of substituted ferulic acid amide derivatives 7 and the corresponding hydrogenated ferulic acid
amide derivatives 13 were synthesized and evaluated for their antiviral and insecticidal activities. The majority of the
synthesized compounds exhibited good levels of antiviral activity against the tobacco mosaic virus (TMW), with
compounds 7a, 7b and 7d in particular providing higher levels of protective and curative activities against TMV at
500 μg/mL than the control compound ribavirin. Furthermore, these compounds displayed good insecticidal
activities against insects with piercing-sucking mouthparts, which can spread plant viruses between and within
crops.
Conclusions: Two series of ferulic acid derivatives have been synthesized efficiently. The bioassay showed title
compounds not only inhibit the plant viral infection, but also prevented the spread of plant virus by insect vectors.
These findings therefore demonstrate that the ferulic acid amides represent a new template for future antiviral
studies.
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To date, more than 1000 plant viruses, which are grouped
into 73 genera and 49 families, have been reported in the
literature. Many of these viruses cause a significant num-
ber of serious plant diseases, resulting in an estimated $60
billion (USD) loss in crop yields worldwide each year [1].
Although plant viruses are relatively simple at the genetic
level, it remains difficult to prevent or control their spread,
and plant viruses can therefore have a devastating impact
on crop growth. Consequently, plant viruses themselves
have often been referred to as “plant cancer”.
Several different chemotherapeutic agents, including syn-
thetic nucleosides such as ribavirin [2], tiazofurin [3],* Correspondence: zwg@nankai.edu.cn
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reproduction in any medium, provided the orselenazofurin, and benzamide riboside; non-nucleoside-type
compounds such as dufulin [4], and mycophenolic acid;
and natural products such as ningnanmycin [5], have been
reported to effectively inhibit virus replication and suppress
the virus symptoms [6,7]. These compounds, however, do
not prevent plants from becoming infected. Many viruses
are spread by insect vectors between and within crops.
Strategies which suppress insect populations below a
threshold level could potentially reduce the damage caused
by transmitted plant viruses [8]. Aphids, mites and
nematodes are the largest and most significant insect
vectors. Insecticides, acaricides and nematicides have all
been used successfully to prevent or at least reduce the
spread of viruses [9,10]. Consequently, crop producers must
combine several different tactics to achieve effective levels
of protection against the transmission and replication of
viruses. We envisage that a combination of virucides andal Ltd. This is an Open Access article distributed under the terms of the Creative
commons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Huang et al. Chemistry Central Journal 2013, 7:33 Page 2 of 12
http://journal.chemistrycentral.com/content/7/1/33insecticides will become an attractive choice for the treat-
ment of plant viruses. The simultaneous use of virucides
and insecticides, however, leads to more polluting
contaminants being released into the environment. There-
fore to minimize environmental pollution, the use of
virucides with insecticidal activity would undoubtedly
represents a promising way to treat of plant viruses.
Ferulic acid A (Figure 1) is a natural phenolic compound
that can be isolated from many staple foods, including
fruits, vegetables, cereals, and coffee. This compound and
its derivatives exhibit a wide range of therapeutic effects
[11], with applications including anticancer [12,13], anti-
diabetic [14], cardio protective [15], neuroprotective [16],
and anti-inflammatory activities [17,18]. Phenanthrene-
based tylophorine derivatives B [19] (Figure 1) possessing
ferulic acid amide substructures have been reported to ex-
hibit excellent levels of antiviral activity. Octopamine is
present in high concentrations in various insect tissues.
The octopaminergic system in insects performs insecti-
cidal action with minimum non-target effects [20]. Many
octopamine derivatives exhibit moderate insecticidal activ-
ity [20-24]. With this in mind, we investigate the antiviral
activities of feruloyl octopamine derivatives.
We report two series of compounds, including the
substituted ferulic acid amide derivatives 7 and the
corresponding hydrogenated ferulic acid amide derivatives
13. Both series were evaluated by random screening and
possess excellent levels of antiviral activity, together with
good levels of insecticidal activity.
Results and discussion
Chemistry
All of the ferulic acid amide derivatives were prepared
















Figure 1 Chemical structures of Ferulic acid A, tylophorine derivativeFerulic acid 1 was acetylated with acetic anhydride in
aqueous sodium hydroxide solution in the absence of a
protecting group on the carboxylic acid. The resulting O-
acetylferulic acid 2 was then transformed into the
corresponding acid chloride 3 by reaction with thionyl
chloride. Compound 3 was then readily converted to the
ferulic acid amide derivatives 4 via reaction with a series of
substituted 2-amino-1-phenylethanones, which were
obtained by the reaction of 2-bromo-1-phenylethanone
with urotropine. The carbonyl compound 4 was then
reduced to the corresponding alcohol with sodium
borohydride and the acetyl group subsequently hydrolyzed
with NaOH in a one-pot synthesis to give the phenolic
compound 5. Alkylation of the phenolic hydroxyl group of
compound 5 yielded compound 6, which was subsequently
alkylated with a bromoalkane, using NaH to generate the
necessary requisite alkoxide, to give the N-(2-alkoxy-2-
phenylethyl) ferulic acid amide derivatives 7.
The corresponding hydrogenated ferulic acid amide
derivatives were prepared in an analogous manner via
the two key hydrogenated intermediates ethyl ferulate 8
and hydrogenated ferulic acid 11, as shown in Scheme 2.
The hydrogenation reaction of ferulic acid only
proceeded in the presence of HCl, which effectively
facilitated the concomitant esterification of the carboxylic
acid to the corresponding ethyl ester. Thus, the phenolic
ester 8 was prepared by catalytic hydrogenation of the
ferulic acid 1 using Pd/C and H2 (1 atm) in the presence
of concentrated HCl. Compound 8 acted as a key inter-
mediate in the synthesis in which R2 was always the same.
Traditional methods for the synthesis of amides suffer
from several disadvantages, including long reaction times
and handling issues. The synthesis of amide 9 occurred via
a reactive acid chloride intermediate, and this synthesis







































































Scheme 1 Synthesis of ferulic acid amide derivatives 7.
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deprotection reactions. Attempts to reduce the numbers
of steps via the direct condensation of the ester 8 were un-
successful, even at high temperatures (160–180°C) under
solvent-free conditions. Microwave irradiation has been
used to successfully reduce the chemical reaction time as
well as the occurrence of side reactions, whilst increasing
yields and improving reproducibility. Through our re-
search, we developed an eco-friendly and high-yielding
procedure for the synthesis of ferulic acid amides 9 via the
hydrogenation of ethyl ferulate 8 followed by amidation
with 2-amino-1-phenylethanol under microwave irradi-
ation at 130°C for 30 min in free-solvent conditions. The
alkylation product 10 was obtained by alkylation of the
phenolic hydroxyl group of compound 9 with bromoalkane
and NaOH.
When R1 was a methyl group, the saturated acid 12



































Scheme 2 Synthesis of hydrogenated ferulic acid amide derivatives 1ferulic acid 11 using Pd/C and H2 (1 atm) in the absence
of concentrated HCl. The mixed carbonic anhydride
method is a simple and mild amidation method, which
has been used extensively for the activation of acyl
peptides and subsequent formation of peptide bonds
without the occurrence of racemization. Amide 10 (R1 =
methyl) was prepared according to “the mixed anhyd-
ride” method in satisfactory yield. The use of alternative
amidation methods, including acid chloride formation
and the use of N,N'-dicyclohexylcarbodiimide (DCC),
provided poor results in comparison.
The reaction of compound 10 with a bromoalkane
following the deprotonation of 10 with NaH gave the
N-(2-alkoxy-2-phenylethyl) hydrogenated ferulic acid
amide derivative 13 by alkylation.
The structures of all new compounds were confirmed
by their spectra (1H NMR, 13 NMR and HRMS) data
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Table 1 In vivo insecticidal activities and antiviral activities of the investigated compounds
Compd. R2 R1 R3 Insecticidal activities Anti-TMV activities
A. fabae Scopoli T. cinnabarinus C. pipiens pallens Protection effect Curative effect
200 μg/mL 200 μg/mL 2 μg/mL 500 μg/mL 500 μg/mL
7a H n-Pr propynyl 78 70 30 40.7 46.4
7b p-Cl Me Me 90 70 70 32.4 37.2
7c p-Cl Me Et 48 50 60 0 18.6
7d p-Cl Me propynyl 81 70 10 24.8 39.5
7e p-Cl Me allyl 70 0 60 0 28.5
7f p-Cl Me benzyl 92 60 10 0 0
7g p-Cl n-Pr Me 0 0 40 24.3 27.7
7h p-Cl n-Pr Et 70 70 30 5.3 12.6
7i p-Cl n-Pr n-Pr 20 20 40 11.3 30.7
7j p-Cl n-Pr propynyl 50 60 100 0 0
7k p-Cl n-Pr allyl 71 75 60 0 5.6
7l p-Cl n-Pr benzyl 0 50 50 13.4 0
7m p-Cl propynyl Me 20 30 30 34.2 36.9
7n p-Cl propynyl propynyl 0 0 60 21 22.7
7o p-Cl allyl allyl 0 0 40 -a -
7p p-Cl benzyl benzyl 0 0 60 17.5 23.8
13a H Me benzyl 0 0 - 7.8 23.5
13b p-Cl Me propynyl 0 0 - 27.3 30.4
13c p-Cl Me benzyl 0 0 - 0 7.6
13d p-Cl n-Pr Me 57 50 10 20.6 25.2
13e p-Cl n-Pr Et 18 10 40 17.3 0
13f p-Cl n-Pr propynyl 91 70 30 12.9 10.2
13g p-Cl n-Pr allyl 58 25 40 16.5 12.7
13h p-Cl n-Pr benzyl 92 75 50 27.6 21.6
13i p-Cl propynyl propynyl 42 30 40 14.5 19.6
chlorfenapyr 100 100 100 - -
Ribavirin - - - 32.6 38.5
aNo tested.
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To evaluate the antiviral activities of the synthesized
compounds, the compounds were evaluated relative to
the commercially available plant virucide Ribavirin,
which was used as a control. The in vivo antiviral bio-
assay against tobacco mosaic virus (TMV) was assayed
according the method previously reported in the litera-
ture [25], and the antiviral results of all synthesized
compounds against TMV are listed in Table 1. The
results showed tha the synthesized ferulic acid amide
derivatives exhibited varying degrees of activity against
TMV. Compounds 7a and 7 m exhibited higher levels of
protection activity (40.7 and 34.2%, respectively) than
Ribavirin at 500 μg/mL (32.6%). Compound 7b showed
the same level of protection activity (32.4%) as Ribavirin
at 500 μg/mL (32.6%). Compounds 7a and 7d exhibitedhigher levels of curative activity (46.4 and 39.5%, re-
spectively) than Ribavirin at 500 μg/mL (38.5%).
Compounds 7b and 7 m showed a similar curative activ-
ity level (37.2 and 36.9%, respectively) to Ribavirin at
500 μg/mL.
When the double bond of the ferulic acid amide was
hydrogenated, most of compounds 13 exhibited weaker
levels of antiviral activity than the corresponding ferulic acid
amides 7. Surprisingly, compound 13b also demonstrated
the same excellent levels of protection (27.3%) and curative
(30.4%) activity as the ferulic acid amides 7.
To prevent the spread of viruses by piercing-sucking
insects between and within tobacco plants, the insecti-
cidal activities of the two series were also determined
against Aphis fabae Scopoli, Tetranychus cinnabarinus
and Culex pipiens pallens larvae (Table 1). Of the ferulic
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a chlorine atom, R1 was a methyl group and R3 was either
a methyl, propynyl or benzyl group (7b, 7d and 7f)
demonstrated excellent insecticidal activity against A. fabae
Scopoli at 200 μg/mL (90, 81, and 92%, respectively),
whereas the analogues where R2 was a chlorine atom,
R1 was n-propyl, and R3 was either a ethyl, propynyl or allyl
group (7 h, 7j and 7 k) displayed good insecticidal activity
(70, 50, and 71%, respectively). In a separate experiment,
all of the active compounds identified above exhibited
good insecticidal activity against T. cinnabarinus. The in-
secticidal activities of compounds 7b, 7d, 7f, 7 h, 7j and 7 k
against T. cinnabarinus at 200 μg/mL were 70, 70, 60, 70,
60 and 75%, respectively. When R1 was a hydrogen atom,
compound 7a showed good insecticidal activities against
the two insects. In contrast, the, compounds bearing an
unsaturated substituent on R1 (7 m–7p), proved to be vir-
tually inactive against A. fabae Scopoli and T. cinnabarinus.
The most active of the synthesized compounds also
showed good larvicidal activities against C. pipiens pallens
at 2 μg/mL, with compound 7i exhibiting 100% inhibition
at 2 μg/mL.
Hydrogenation of the double bond of the ferulic acid
amides gave the corresponding saturated analogues 13,
which showed excellent insecticidal activities against the
two insects when R2 was a propyl group. When the propyl
group on R2 was replaced with methyl, the compounds
showed low levels of activity. Compounds 13f and 13 h,
where R3 was either a propynyl or benzyl group, exhibited
higher levels of insecticidal activity than all of the other
compounds against A. fabae Scopoli (91 and 92%, respec-
tively) and T. cinnabarinus (70 and 75%, respectively) at
200 μg/mL.
Compounds 7a, 7b and 7d indicated excellent protec-
tion and curative activities against TMV at 500 μg/mL.
Furthermore, they exhibited good insecticidal activities
against insects with piercing-sucking mouthparts at
200 μg/mL. Although the two series (compounds 7 and
13) had weaker insecticidal activities than that of the com-
mercial pesticide, they effectively controlled replication of
the plant virus whilst simultaneously preventing insects
with piercing-sucking mouthparts, spreading the plant
virus between and within crops, at 500 μg/mL.
Experimental
Instruments
The 1H and 13C NMR spectra were obtained at 400 and
100 MHz, respectively, on a Bruker Avance 400 spectrom-
eter with tetramethylsilane (TMS) as an internal standard.
High resolution mass spectrometry (HRMS) data were
obtained on a VG ZAB HS instrument. The microwave
synthesis was performed in a CEM Discover focused
microwave (2450 MHz, 300 W). Melting points were
determined on an X-4 binocular microscope melting pointapparatus (Beijing Tech Instruments Co., Beijing, China)
and were uncorrected. All chemicals and reagents were
purchased from standard commercial suppliers. All
solvents and liquid reagents were dried according to the
standard methods and distilled prior to use.
Synthesis of compounds
Preparation of O-acetylferulic acid 2
Compound 2 was prepared as a white solid according to
a literature procedure [26].
Preparation of ferulic acid amide derivatives 4
Compound 2 (11.8 g, 50 mmol) was dissolved in SOCl2
(23.8 g) and refluxed for 4 h. The resulting solution was
distilled in vacuo to give compound 3 as a pale yellow
solid.
Substituted 2-amino-1-phenylethanone (60 mmol) was
suspended in a mixture of THF (400 mL) and Et3N
(12.1 g, 120 mmol). The mixture was stirred for 20 min at
room temperature and then cooled to −10°C. A solution
of compound 3 (50 mmol) in THF (100 mL) was then
added to the reaction mixture at this temperature. The re-
action mixture was warmed to ambient temperature and
stirred for 24 h. The resulting mixture was filtrated to re-
move the white precipitation, and the filtrate collected
and distilled in vacuo to give the crude product as a solid
that was purified by crystallization to provide the com-
pound 4.
4a: R2 = Cl, white solid, m.p.: 183–185°C;
1H NMR
(400 MHz, DMSO) δ 2.24 (s, 3H, COCH3), 3.80 (s, 3H,
OCH3), 4.72–4.73 (m, 2H, NHCH2), 6.83 (d, 1H, J =
16.0 Hz, COCH), 7.10–7.34 (m, 3H, Ar-H), 7.42 (d, 1H,
J = 16.0 Hz, Ar-CH), 7.52–7.76 (m, 4H, Ar-H), 8.48 (br,
1H, NH).
4b: R2 = H, white solid, m.p.:149–151°C;
1H NMR
(400 MHz, DMSO) δ 2.31 (s, 3H, COCH3), 3.94 (s, 3H,
OCH3), 4.91–4.92 (m, 2H, NHCH2), 5.89 (br, 1H, NH),
6.43 (d, 1H, J = 16.0 Hz, COCH), 6.75 (br, 1H, OH),
6.91–7.10 (m, 3H, Ar-H), 7.50–7.66 (m, 4H, ArCH+Ar-H),
8.01–8.03 (m, 2H, Ar-H).
Preparation of compound 5
Sodium borohydride was added to a solution of com-
pound 5 (2.5 mmol) in MeOH (40 mL) in a portion-wise
manner and the resulting mixture was stirred at ambient
temperature for 4 h. Water (10 mL) was then added and
the mixture was heated to 60°C for 1 h. The mixture
was then cooled to ambient temperature and the pH
adjusted to pH 6–7 with 2 N aqueous HCl to give a
white precipitate that was collected by filtration, and
purified by recrystallization to provide compound 5.
5a: R2 = Cl, white solid, m.p.: 186–189°C;
1H NMR
(400 MHz, DMSO) δ 3.14–3.44 (m, 3H, NHCH2+CHOH),
3.77 (s, 3H, OCH3), 4.63 (dd, 1H, J = 4.8 Hz, J = 7.6 Hz,
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6.84–7.09 (m, 3H, Ar-H), 7.26–7.33 (m, 4H, Ar-H), 7.60 (d,
1H, J = 16.0 Hz, Ar-CH), 9.42 (br, 1H, ArOH).
5b: R2 = H, white solid, m.p.: 150–153°C;
1H NMR
(400 MHz, DMSO) δ 3.94 (s, 3H, OCH3), 4.91–4.92 (m, 3H,
NHCH2+OCH), 5.89 (br, 1H, NH), 6.43 (d, 1H, J = 16.0 Hz,
COCH), 6.75 (br, 1H, OH), 6.91–7.10 (m, 3H, Ar-H),
7.50–7.66 (m, 4H, Ar-CH+Ar-H), 8.01–8.03 (m, 2H,
Ar-H).
Preparation of the compounds 6
Sodium hydroxide (0.90 g, 22 mmol) and compound 5
(20 mmol) were dissolved in a mixture of ethanol
(120 mL) and water (40 mL) and the resulting mixture
was stirred at ambient temperature for 30 min. Alkyl
bromide was then added slowly at ambient temperature.
The reaction mixture was then stirred at 60–70°C for
10 h. The mixture was then cooled to ambient
temperature and acidified to pH 1 with 2 N aqueous
HCl, before being concentrated in vacuo, filtered,
washed with water, dried, and recrystallized to give the
title compound 6.
6a: R2 = Cl, R1 = n-Pr, white solid, m.p.: 194–196°C;
1H NMR (400 MHz, DMSO) δ 0.97 (t, 3H, J = 7.6 Hz,
CH2CH3), 1.67–1.77 (m, 2H, CH3CH2), 3.23–3.30,3.37–
3.43 (m, 2H, NHCH2), 3.79 (s, 3H, OCH3), 3.94 (t, 2H, J
= 6.4 Hz, ArOCH2), 4.65–4.69 (m, 1H, OCH), 5.63–5.64
(m, 1H, OH), 6.58 (d, 1H, J = 16.0 Hz, COCH), 6.96–
7.14 (m, 3H, Ar-H), 7.31–7.41 (m, 4H, Ar-CH+Ar-H),
8.04 (t, 1H, J = 5.2 Hz, NH).
6b: R2 = Cl, R1 = Me, white solid, m.p.: 195–197°C;
1H NMR (400 MHz, DMSO) δ 2.48 (br, 1H, OH), 3.41–
3.45 (m, 1H, NHCH2), 3.80–3.99 (m, 7H, NHCH2+m-
ArOCH3+p-ArOCH3), 4.91–4.92 (m, 1H, OCH), 6.02
(br, 1H, NH), 6.26 (d, 1H, J = 16.0 Hz, COCH), 6.84–
7.09 (m, 3H, Ar-H), 7.26–7.33 (m, 4H, Ar-H), 7.60 (d,
1H, J = 16.0 Hz, Ar-CH).
6c: R2 = Cl, R1 = propynyl, white solid, m.p.: 180–182°C;
1H NMR (400 MHz, DMSO) δ 3.24–3.44 (m, 3H,
NHCH2+C≡CH), 3.59 (br, 1H, OH), 3.81 (s, 3H, OCH3),
4.67 (br, 1H, OCH), 4.81–4.82 (m, 2H, OCH2), 5.64–
5.65 (m, 1H, COCH) 7.03–7.18 (m, 3H, Ar-H), 7.32–
7.41 (m, 5H, Ar-H+Ar-CH), 8.05 (t, 1H, J = 5.6 Hz, NH)
6d: R2 = H, R1 = n-Pr, white solid, m.p.: 140–142°C;
1H NMR (400 MHz, DMSO) δ 0.94 (t, 3H, J = 7.2 Hz,
CH2CH3), 1.66–1.74 (m, 2H, CH3CH2), 3.33–3.44 (m,
2H, NHCH2), 3.77 (s, 3H, OCH3), 3.90 (t, 2H, J =
6.0 Hz, ArOCH2), 4.62–4.64 (m, 1H, OCH), 5.53–5.54
(m, 1H, OH), 6.78 (d, 1H, J = 16.0 Hz, COCH), 6.93–
7.11 (m, 3H, Ar-H), 7.22–7.24 (m, 1H, Ar-CH), 7.29–
7.33 (m, 5H, Ar-H), 8.03 (br, 1H, NH).
10a: R2 = Cl, R1 = n-Pr, white solid, m.p.: 100–102°C;
1H NMR (400 MHz, CDCl3) δ 1.02 (t, 3H, J = 7.2 Hz,
CH2CH3), 1.80–1.88 (m, 2H, CH3CH2), 2.46 (t, 2H, J =7.2 Hz, COCH2), 2.89 (t, 2H, J = 7.2 Hz, Ar-CH2), 3.58–
3.63 (m, 2H, NHCH2), 3.84 (s, 3H, OCH3), 3.94 (t, 2H, J
= 6.8 Hz, ArOCH2), 4.73–4.74 (m, 1H, OCH), 5.75 (br,
1H, NH), 6.68–6.80 (m, 3H, Ar-H), 7.20–7.29 (m, 4H,
Ar-H).
10b: R2 = H, R1 = Me, yellow solid, m.p.: 94–95°C;
1H
NMR (400 MHz, CDCl3) δ 2.50 (t, 2H, J = 7.2 Hz,
CH2CH2), 2.94 (t, 2H, J = 7.2 Hz, CH2CH2), 3.28–3.35
(m, 1H, CHCH2), 3.65–3.72 (m, 1H, CHCH2), 3.88 (s,
3H, o-ArOCH3), 3.89 (s, 3H, p-ArOCH3), 4.80 (dd, 1H, J
= 2.8 Hz, CH2CH), 5.85 (br, 1H, CONH), 6.74–6.83 (m,
3H, Ar-H), 7.31–7.36 (m, 5H, Ar-H).
Preparation of the compounds 7
Sodium hydride (70 mg, 3.0 mmol) was added to a solu-
tion of compound 6 (or 10) (2.5 mmol) in dry THF
(70 mL), and the resulting mixture was stirred under N2
at ambient temperature for 1 h. The alkyl bromide (3.7 -
mmol) was then added and the resulting mixture
agitated at ambient temperature for 24 h. The reaction
mixture was distilled to dryness in vacuo to give a resi-
due that was purified by flash chromatography eluting
with petroleum ether-EtOAc (3: 2) to give compound 7.
7a: R2 = H, R1 = n-Pr, R3 = propynyl, white solid, m.
p.:91–92°C; 1H NMR (400 MHz, CDCl3) δ 1.03 (t, 3H,
J = 7.2 Hz, CH2CH3), 1.82–1.91 (m, 2H, CH3CH2), 2.43
(s, 1H, CH2C≡CH), 3.28–3.34 (m, 1H, NHCH2), 3.88–
3.95 (m, 5H, ArOCH3+NHCH2+CH≡CCH2), 3.99 (t, 2H,
J = 6.8 Hz, ArOCH2), 4.16 (d, 1H, J = 16.0 Hz,
CHOCH2), 4.67 (dd, 1H, J = 2.8 Hz, J = 9.2 Hz, OCH),
6.15 (br, 1H, NH), 6.30 (d, 1H, J = 16.0 Hz, COCH),
6.84 (d, 1H, J = 8.0 Hz, Ar-H), 7.03–7.07 (m, 2H, Ar-
H), 7.32–7.39 (m, 5H, Ar-H), 7.57 (d, 1H, J = 16.0 Hz,
Ar-CH); 13C NMR (101 MHz, CDCl3) δ 166.1, 150.2,
149.4, 141.2, 138.1, 128.8, 128.6, 127.6, 126.9, 122.1,
118.3, 112.4, 110.1, 79.7, 79.6, 74.7, 70.4, 56.0, 56.0,
45.6, 22.4, 10.4; HRMS (ESI) (M+Na)+ Calcd for
C24H27NO4Na
+ 416.1832, found 416.1838.
7b: R2 = p-Cl, R1 = Me, R3 = Me, white solid, m.p.: 92–
93°C; 1H NMR (400 MHz, CDCl3) δ 3.21–3.29 (m, 4H,
CHOCH3+NHCH2), 3.80–3.93 (m, 7H, m-ArOCH3+p-
ArOCH3+NHCH2), 4.30 (dd, 1H, J = 5.2 Hz, J = 8.8 Hz,
OCH), 6.02 (br, 1H, NH), 6.28 (d, 1H, J = 16.0 Hz, COCH),
6.86 (d, 1H, J = 8.0 Hz, Ar-H), 7.03–7.10 (m, 2H, Ar-H),
7.26–7.36 (m, 4H, Ar-H), 7.58 (d, 1H, J = 16.0 Hz, Ar-CH);
13C NMR (101 MHz, CDCl3) δ 166.1, 150.6, 149.1, 141.1,
137.7, 133.9, 128.8, 128.1, 127.7, 122.1, 118.4, 111.0, 109.6,
81.8, 56.9, 55.9, 55.8, 45.8; HRMS (ESI) (M+Na)+ Calcd for
C20H22ClNO4Na
+ 398.1130, found 398.1138.
7c: R2 = p-Cl, R1 = Me, R3 = Et, white solid, m.
p.:97–99°C; 1H NMR (400 MHz, CDCl3) δ 1.19 (t, 3H,
J = 6.8 Hz, CH2CH3), 3.23–3.49 (m, 3H, CH3CH2
+NHCH2), 3.79–3.89 (m, 7H, m-ArOCH3+p-ArOCH3
+NHCH2), 4.41 (dd, 1H, J = 2.8 Hz, J = 8.0 Hz,
Huang et al. Chemistry Central Journal 2013, 7:33 Page 7 of 12
http://journal.chemistrycentral.com/content/7/1/33OCH), 6.09 (br, 1H, NH), 6.28 (d, 1H, J = 16.0 Hz,
COCH), 6.84 (d, 1H, J = 7.2 Hz, Ar-H), 7.02 (s, 1H, Ar-H),
7.08 (d, 1H, J = 7.2 Hz, Ar-H), 7.26–7.32 (m, 4H, Ar-H),
7.37 (d, 1H, J = 16.0 Hz, Ar-CH); 13C NMR (101 MHz,
CDCl3) δ 166.1, 150.6, 149.1, 141.1, 138.5, 133.7, 128.8,
128.0, 127.7, 122.1, 118.4, 111.0, 109.6, 79.8, 64.5, 55.9,
55.9, 45.8, 15.3; HRMS (ESI) (M+Na)+ Calcd for
C21H24ClNO4Na
+ 412.1286, found 412.1294.
7d: R2 = p-Cl, R1 = Me, R3 = propynyl, white solid, m.
p.:137–138°C; 1H NMR (400 MHz, CDCl3) δ 2.43 (s, 1H,
C≡CH), 3.25–3.30 (m, 1H, NHCH2), 3.87–3.99 (m, 8H,
m-ArOCH3 + p-ArOCH3+ NHCH2), 4.16 (d, 1H, J =
16.0 Hz, OCH2), 4.67 (dd, 1H, J = 3.6Hz, J = 8.8 Hz,
OCH), 6.09 (br, 1H, NH), 6.30 (d, 1H, J = 16.0 Hz,
COCH), 6.84–6.87 (m, 1H, Ar-H), 7.03–7.10 (m, 2H,
Ar-H), 7.29–7.36 (m, 4H, Ar-H), 7.58 (d, 1H, J =
16.0 Hz, Ar-CH); 13C NMR (101 MHz, CDCl3) δ 166.1,
150.7, 149.1, 141.3, 136.7, 134.3, 129.0, 128.3, 127.7,
122.1, 118.23, 111.1, 109.6, 79.3, 79.0, 75.0, 56.1, 56.0,
55.9, 45.5; HRMS (ESI) (M+Na)+ Calcd for
C22H22ClNO4Na
+ 422.1130, found 422.1133.
7e: R2 = p-Cl, R1 = Me, R3 = allyl, white solid, m.
p.:115–116°C; 1H NMR (400 MHz, CDCl3) δ 3.27–3.33
(m, 1H, NHCH2), 3.82–3.91 (m, 9H, m-ArOCH3+p-
ArOCH3+ NHCH2+OCH2), 4.49 (dd, 1H, J = 3.6Hz, J =
8.0 Hz, OCH), 5.17–5.27 (m, 2H, CH=CH2), 5.86–5.92
(m, 1H, CH2=CH), 6.03 (br, 1H, NH), 6.28 (d, 1H, J =
16.0 Hz, COCH), 6.86 (d, 1H, J = 8.0 Hz, Ar-H), 7.03
(s,1H, Ar-H), 7.09 (d, 1H, J = 8.0 Hz, Ar-H), 7.28–7.35
(m, 4H, Ar-H), 7.57 (d, 1H, J = 16.0 Hz, Ar-CH); 13C
NMR (101 MHz, CDCl3) δ 166.1, 150.6, 149.1, 141.2,
137.94, 134.3, 133.9, 128.9, 128.1, 127.7, 122.1, 118.3,
117.4, 111.0, 109.6, 79.3, 69.8, 56.0, 55.9, 45.8; HRMS
(ESI) (M+Na)+ Calcd for C22H24ClNO4Na
+ 424.1286,
found 424.1290.
7f: R2 = p-Cl, R1 = Me, R3 = benzyl, white solid, m.
p.:104–105°C; 1H NMR (400 MHz, CDCl3) δ 3.29–3.36
(m, 1H, NHCH2), 3.83–3.91 (m, 7H, p-ArOCH3+m-
ArOCH3+NHCH2), 4.30 (d, 1H, J = 12.0 Hz, Ar-CH2),
4.48–4.55 (m, 2H, OCH+Ar-CH2), 5.99 (br, 1H, NH),
6.22 (d, 1H, J = 16.0 Hz, COCH), 6.86 (d, 1H, J =
8.0 Hz, Ar-H), 7.02 (s, 1H, Ar-H), 7.08 (d, 1H, J =
8.8 Hz, Ar-H), 7.30–7.38 (m, 9H, Ar-H), 7.54 (d,
1H, J = 16.0 Hz, Ar-CH); 13C NMR (101 MHz,
CDCl3) δ 166.1, 150.6, 149.1, 141.1, 137.9, 137.8,
134.0, 128.9, 128.6, 128.2, 127.9, 127.9, 127.7, 122.1,
118.3, 111.1, 109.6, 79.6, 70.9, 56.0, 55.9, 45.8;
HRMS (ESI) (M+H)+ Calcd for C26H26ClNO4H
+
452.1623, found 452.1622.
7g: R2 = p-Cl, R1 = n-Pr; R3 = Me, white solid, m.
p.:128–129°C; 1H NMR (400 MHz, CDCl3) δ 0.98 (t, 3H,
J = 7.2 Hz, CH2CH3), 1.77–1.86 (m, 2H, CH3CH2),
3.16–3.23 (m, 4H, CHOCH3+NHCH2), 3.73–3.80 (m,
1H, NHCH2), 3.83 (s, 3H, ArOCH3), 3.94 (t, 2H, J =6.8 Hz, ArOCH2), 4.25 (dd, 1H, J = 3.6 Hz, J = 8.8 Hz,
Ar-CH), 5.92 (br, 1H, NH), 6.20 (d, 1H, J = 16.0 Hz,
COCH), 6.79 (d, 1H, J = 8.8 Hz, Ar-H), 6.97–7.02 (m,
2H, Ar-H), 7.20–7.30 (m, 4H, Ar-H), 7.50 (d, 1H, J =
16.0 Hz, Ar-CH; 13C NMR (101 MHz, CDCl3) δ 166.1,
150.3, 149.4, 141.3, 137.7, 133.9, 128.9, 128.1, 127.5,
122.1, 118.1, 112.4, 110.1, 81.8, 70.4, 57.0, 56.0, 45.7,
22.4, 10.4; HRMS (ESI) (M+Na)+ Calcd for
C22H26ClNO4Na
+ 426.1443, found 426.1440.
7h: R2 = p-Cl, R1 = n-Pr, R3 = Et, white solid, m.p.:89–
91°C; 1H NMR (400 MHz, CDCl3) δ 0.98 (t, 3H, J =
7.2 Hz, OCH2CH3), 1.13 (t, 3H, J = 6.8 Hz,
OCH2CH2CH3), 1.77–1.87 (m, 2H, OCH2CH2), 3.17–
3.23 (m, 1H, NHCH2), 3.27–3.40 (m, 2H, CHOCH2),
3.71–3.78 (m, 1H, NH), 3.83 (s, 3H, OCH3), 3.94 (t, 2H,
J = 6.8 Hz, ArOCH2), 4.35 (dd, 1H, J = 3.6 Hz, J =
8.8 Hz, OCH), 5.93 (br, 1H, NH), 6.20 (d, 1H, J =
16.0 Hz, COCH), 6.78 (d, 1H, J = 8.8 Hz, Ar-H), 6.97–
7.02 (m, 2H, Ar-H), 7.21–7.28 (m, 4H, Ar-H), 7.50 (d,
1H, J = 16.0 Hz, Ar-CH); 13C NMR (101 MHz, CDCl3) δ
166.1, 150.2, 149.4, 141.2, 138.5, 133.7, 128.8, 128.0,
127.6, 122.1, 118.2, 112.4, 110.1, 79.9, 70.4, 64.6, 56.0,
45.8, 22.4, 15.3, 10.4; HRMS (ESI) (M+Na)+ Calcd for
C23H28ClNO4Na
+ 440.1599, found 440.1607.
7i: R2 = p-Cl, R1 = n-Pr, R3 = n-Pr, white solid, m.
p.:81–83°C; 1H NMR (400 MHz, CDCl3) δ 0.89-0.92 (m,
3H, CHOCH2CH2CH3), 1.03 (t, 3H, J = 6.4 Hz,
ArOCH2CH2CH3), 1.56–1.61 (m, 2H, CHOCH2CH2),
1.85–1.90 (m, 2H, ArOCH2CH2), 3.25–3.33 (m, 3H,
CHOCH2+NHCH2), 3.78–3.89 (m, 4H, OCH3+NHCH2),
3.99 (t, 2H, J = 6.4 Hz, ArOCH2), 4.40 (dd, 1H, J =
2.8 Hz, J = 9.2 Hz, OCH), 6.04 (br, 1H, NH), 6.26 (d,
1H, J = 16.0 Hz, COCH), 6.84 (d, 1H, J = 8.0 Hz, Ar-H),
7.02–7.07 (m, 2H, Ar-H), 7.26–7.34 (m, 4H, Ar-H), 7.56
(d, 1H, J = 16.0 Hz, Ar-CH); 13C NMR (101 MHz,
CDCl3) δ 166.1, 150.3, 149.4, 141.2, 138.5, 133.7, 128.8,
128.0, 127.6, 122.1, 118.2, 112.4, 110.2, 80.0, 70.9, 70.4,
56.0, 45.9, 23.0, 22.4, 10.7, 10.4; HRMS (ESI) (M+Na)+
Calcd for C24H30ClNO4Na
+ 454.1392, found 454.1392.
7j: R2 = p-Cl, R1 = n-Pr, R3 = propynyl, white solid, m.
p.:71–72°C; 1H NMR (400 MHz, CDCl3) δ 1.03 (t, 3H, J
= 7.2 Hz, CH2CH3), 1.83–1.92 (m, 2H, CH3CH2), 2.43
(s, 1H, C≡CH), 3.24–3.30 (m, 1H, NHCH2), 3.86–3.92
(m, 5H, ArOCH3+NHCH2+CH≡CCH2), 4.00 (t, 2H, J =
6.8 Hz, ArOCH2), 4.15 (d, 1H, J = 16.0 Hz, CHOCH2),
4.66 (dd, 1H, J = 2.8 Hz, J = 8.8 Hz, OCH), 6.10 (br, 1H,
NH), 6.29 (d, 1H, J = 16.0 Hz, COCH), 6.84 (d, 1H, J =
8.8 Hz, Ar-H), 7.03–7.07 (m, 2H, Ar-H), 7.28–7.36 (m,
4H, Ar-H), 7.57 (d, 1H, J = 16.0 Hz, Ar-CH); 13C NMR
(101 MHz, CDCl3) δ 166.2, 150.3, 149.4, 141.3, 136.7,
134.3, 129.0, 128.3, 127.5, 122.1, 118.1, 112.4, 110.1,
79.3, 79.0, 75.0, 70.4, 56.1, 56.0, 45.5, 22.4, 10.4; HRMS
(ESI) (M+H)+ Calcd for C24H26ClNO4H
+ 428.1623,
found 428.1624.
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p.:86–88°C; 1H NMR (400 MHz, CDCl3) δ 1.03 (t, 3H, J
= 7.2 Hz, CH2CH3), 1.83–1.92 (m, 2H, CH3CH2), 3.26–
3.33 (m, 1H, NHCH2), 3.80–3.95 (m, 6H, OCH3 +
NHCH2 + CH2=CHCH2), 4.00 (t, 2H, J = 6.8 Hz,
ArOCH2), 4.49 (dd,1H, J = 3.2 Hz, J = 8.4 Hz, OCH),
5.17–5.27 (m, 2H, CH=CH2), 5.84–5.93 (m, 1H,
CH2=CH), 6.03 (br, 1H, NH), 6.27 (d, 1H, J = 16.0 Hz,
COCH), 6.85 (d, 1H, J = 8.0 Hz, Ar-H), 7.03–7.04 (m,
2H, Ar-H), 7.27–7.35 (m, 4H, Ar-H), 7.57 (d, 1H, J =
16.0 Hz, Ar-CH); 13C NMR (101 MHz, CDCl3) δ 166.2,
150.3, 149.4, 141.3, 138.0, 134.3, 133.9, 128.8, 128.1,
127.5, 122.1, 118.1, 117.4, 112.4, 110.1, 79.3, 70.4, 69.8,
56.0, 45.8, 22.4, 10.4; HRMS (ESI) (M+Na)+ Calcd for
C24H28ClNO4Na
+ 452.1599, found 452.1603.
7l: R2 = p-Cl, R1 = n-Pr, R3 = benzyl, white solid, m.
p.:69–71°C; 1H NMR (400 MHz, CDCl3) δ 1.04 (t, 3H, J
= 7.2 Hz, CH2CH3), 1.84–1.92 (m, 2H, CH3CH2), 3.29–
3.36 (m, 1H, NHCH2), 3.83–3.90 (m, 4H, OCH3 +
NHCH2), 4.00 (t, 2H, J = 6.8 Hz, ArOCH2), 4.30 (d, 1H,
J = 12.0 Hz, Ar-CH2), 4.48–4.55 (m, 2H, Ar-CH2 +
OCH), 6.85 (d, 1H, J = 8.8 Hz, Ar-H), 7.02–7.07 (m, 2H,
Ar-H), 7.30–7.38 (m, 9H, Ar-H), 7.54 (d, 1H, J =
16.0 Hz, Ar-CH); 13C NMR (101 MHz, CDCl3) δ 166.2,
150.3, 149.4, 141.2, 137.9, 137.9, 134.0, 128.9, 128.6,
128.2, 127.9, 127.9, 127.6, 122.1, 118.2, 112.4, 110.2,
79.6, 70.9, 70.4, 56.0, 45.8, 22.4, 10.5; HRMS (ESI) (M
+Na)+ Calcd for C28H30ClNO4Na
+ 502.1756, found
502.1757.
7m: R2 = p-Cl, R1 = propynyl, R3 = Me, white solid, m.
p.:134–135°C; 1H NMR (400 MHz, CDCl3) δ 2.47 (s, 1H,
C≡CH), 3.16–3.23 (m, 4H, CHOCH3 + NHCH2), 3.74–
3.82 (m, 1H, NHCH2), 3.85 (s, 3H, ArOCH3), 4.25 (dd,
1H, J = 3.6 Hz, J = 8.4 Hz, OCH), 4.73 (s, 2H, ArOCH2),
5.95 (br, 1H, NH), 6.23 (d, 1H, J = 16.0 Hz, COCH),
6.94–6.99 (m, 2H, Ar-H), 7.03 (d, 1H, J = 8.0 Hz, Ar-H),
7.20–7.30 (m, 4H, Ar-H), 7.51 (d, 1H, J = 16.0 Hz, Ar-C
H); 13C NMR (101 MHz, CDCl3) δ 166.0, 149.9, 149.7,
141.2, 137.6, 134.0, 128.9, 128.1, 127.2, 121.6, 118.8,
113.8, 110.2, 81.8, 78.2, 76.3, 57.0, 56.6, 56.0, 45.7;
HRMS (ESI) (M+H)+ Calcd for C22H22ClNO4H
+
400.1310, found 400.1305.
7n: R2 = p-Cl, R1 = propynyl, R3 = propynyl, yellow
solid, m.p.:101–104°C; 1H NMR (400 MHz, CDCl3) δ
2.46 (t, J = 2.4 Hz, 1H, CHOCH2C≡CH), 2.52 (t, J =
2.4 Hz, 1H ArOCH2C≡CH), 3.28–3.34 (m, 1H, NHCH2),
3.92–3.97 (m, 5H, OCH3+NHCH2+CHOCH2), 4.17 (dd,
1H, J = 15.7, 2.4 Hz, CHOCH2), 4.70 (dd, 1H, J = 9.0,
3.5 Hz, OCH), 4.82 (d, J = 2.3 Hz, 2H, ArOCH2), 6.09
(br, 1H, NH), 6.30 (d, 1H, J = 15.5 Hz, COCH), 7.04–
7.11 (m, 3H, Ar-H), 7.28–7.40 (m, 4H, Ar-H), 7.60 (d,
1H, J = 15.5 Hz, Ar-CH); 13C NMR (101 MHz, CDCl3) δ
166.0, 149.7, 148.3, 141.1, 136.6, 134.4, 129.0, 128.9,
128.3, 121.6, 118.8, 113.8, 110.2, 79.3, 79.0, 78.1, 77.4,77.0, 76.7, 76.2, 75.0, 56.6, 56.1, 56.0, 45.5; HRMS (ESI)
(M+Na)+ Calcd for C24H22ClNO4Na
+ 446.1130, found
446.1132.
7o: R2 = p-Cl, R1 = allyl, R3 = allyl, white solid, m.p.:
86–88°C; 1H NMR (400 MHz, CDCl3) δ 3.27–3.32 (m,
1H, NHCH2), 3.73–4.05 (m, 6H, OCH3+CHOCH2
+NHCH2), 4.47–4.63 (m, 3H, OCH+ArOCH2), 5.16–
5.42 (m, 4H, CHOCH2=CHCH2+ArOCH2=CHCH2),
5.84–6.09 (m, 3H, CHOCH2CH+ArOCH2CH +NH),
6.26 (d, 1H, J = 16.0 Hz, COCH), 6.84 (d, 1H, J =
8.0 Hz, Ar-H), 7.03–7.05 (m, 2H, Ar-H), 7.25–7.34 (m,
4H, Ar-H), 7.55 (d, 1H, J = 16.0Hz, Ar-CH);13C NMR
(101 MHz, CDCl3) δ 166.0, 149.6, 149.5, 141.3, 137.9,
134.3, 134.0, 132.8, 128.9, 128.1, 127.9, 121.9, 118.4,
118.3, 117.5, 112.9, 110.0, 79.4, 69.8, 69.8, 56.0, 45.7;
HRMS (ESI) (M+Na)+ Calcd for C24H26ClNO4Na
+
450.1443, found 450.1449.
7p: R2 = p-Cl, R1 = benzyl, R3 = benzyl, white solid, m.
p.:131–132°C; 1H NMR (400 MHz, CDCl3) δ 3.29–3.35
(m, 1H, NHCH2), 3.83–3.92 (m, 4H, OCH3+NHCH2),
4.30 (d, 1H, J = 11.2 Hz, CHOCH2), 4.49–4.54 (m, 2H,
CHOCH2+OCH), 5.19 (s, 2H, ArOCH2), 5.96 (br, 1H,
NH), 6.20 (d, 1H, J = 16.0 Hz, COCH), 6.86 (d, 1H, J =
8.8 Hz, Ar-H), 7.00–7.04 (m, 2H, Ar-H), 7.30–7.44 (m,
14H, Ar-H), 7.52 (d, 1H, J = 16.0 Hz, Ar-CH); 13C NMR
(101 MHz, CDCl3) δ 166.0, 149.8, 149.7, 141.2, 137.8,
137.8, 136.7, 134.0, 129.0, 128.7, 128.6, 128.2, 128.1,
128.0, 128.0, 127.9, 127.2, 121.9, 118.4, 113.5, 110.2,
79.6, 71.0, 70.9, 56.0, 45.7; HRMS (ESI) (M+Na)+ Calcd
for C32H30ClNO4Na
+ 550.1756, found 550.1759.
General procedure for the preparation of the compound 8
To a 500 mL tube-shaped flask, equipped with a mag-
netic stirrer, hydrogen balloon and a vacuum outlet was
added 10% Pd/C (1 g). The flask was evacuated for
5 min at 0.001 mm Hg and flushed with H2. The evacu-
ation cycle was repeated four times before the catalyst
was suspended in EtOH (170 mL) and ferulic acid 1
(20 g, 0.1 mol) and concentrated hydrochloric acid
(10 mL) were added. The resulting mixture was then
stirred under a hydrogen atmosphere at 40°C for 20 h.
Upon completion (monitored by TLC by the disappear-
ance of the starting material), the solution was filtered
through celite and the filter washed with EtOH (3 ×
30 mL). The combined filtrates were then distilled in
vacuo and the resulting residue dried at 20–23°C for 1 h
at 0.01 mm Hg to give compound 8 (21.95 g).
Preparation of the compound 9
Substituted 2-amino-1-phenylethanol (3.6 g, 21 mmol)
and DMAP (0.244 g, 2 mmol) were added to compound
9 (4.5 g, 20 mmol) in a microwave vial. The vial was
then sealed and irradiated in a microwave reactor at
130°C (10 bar) for 30 min. The reaction mixture was
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EtOAc. The combined organic phases were then washed
with brine, dried over MgSO4 and evaporated to dryness
to give the crude product as a residue, which was puri-
fied by chromatography on silica gel using petroleum
ether (60–90%) and ethyl acetate as the eluent to afford
a pale purple solid 9, yield: 60%, m.p.: 108–110°C. 1H
NMR (400 MHz, CDCl3) δ 2.40 (t, 2H, J = 7.2 Hz,
COCH2), 2.83 (t, 2H, J = 6.8 Hz, Ar-CH2), 3.15–3.21 (m,
1H, NHCH2),3.54–3.58 (m, 1H, NHCH2), 3.80 (s, 3H,
OCH3), 4.68–4.69 (m, 1H, OCH), 5.65 (br, 1H, NH),
6.60–6.79 (m, 3H, Ar-H), 7.13–7.24 (m, 4H, Ar-H).
Preparation of the compound 10a-10b
Compound 10 was prepared according to the same pro-
cedure as compound 6.
10a: R2 = Cl, R1 = n-Pr, white solid, m.p.: 100–102°C;
1H NMR (400 MHz, CDCl3) δ 1.02 (t, 3H, J = 7.2 Hz,
CH2CH3), 1.80–1.88 (m, 2H, CH3CH2), 2.46 (t, 2H, J =
7.2 Hz, COCH2), 2.89 (t, 2H, J = 7.2 Hz, Ar-CH2), 3.58–
3.63 (m, 2H, NHCH2), 3.84 (s, 3H, OCH3), 3.94 (t, 2H, J
= 6.8 Hz, ArOCH2), 4.73–4.74 (m, 1H, OCH), 5.75 (br,
1H, NH), 6.68–6.80 (m, 3H, Ar-H), 7.20–7.29 (m, 4H,
Ar-H).
10b: R2 = H, R1 = Me, yellow solid, m.p.: 94–95°C;
1H
NMR (400 MHz, CDCl3) δ 2.50 (t, 2H, J = 7.2 Hz,
CH2CH2), 2.94 (t, 2H, J = 7.2 Hz, CH2CH2), 3.28–3.35
(m, 1H, CHCH2), 3.65–3.72 (m, 1H, CHCH2), 3.88 (s,
3H, o-ArOCH3), 3.89 (s, 3H, p-ArOCH3), 4.80 (dd, 1H, J
= 2.8 Hz, CH2CH), 5.85 (br, 1H, CONH), 6.74–6.83 (m,
3H, Ar-H), 7.31–7.36 (m, 5H, Ar-H).
Preparation of the compound 12
To a 500-mL tube-shaped flask, equipped with a mag-
netic stirrer, hydrogen balloon and a vacuum outlet was
added 10% Pd/C (1.5 g). The flask was evacuated for
5 min at 0.001 mm Hg and flushed with H2. This evacu-
ation cycle was repeated four times before the catalyst
was suspended in a mixture of EtOH (150 mL), EtOAc
(150 mL) and (3,4-dimethoxyphenyl)acrylic acid 1 (15 g,
72 mmol). The resulting mixture was then stirred under
a hydrogen atmosphere at 40°C for 72 h. Upon comple-
tion of the reaction, the solution was filtered through
celite and the celite plug washed with EtOH (3 × 30 mL).
The combined filtrates were then distilled in vacuo to
give the corresponding product 12 as a white solid, m.p.;
92–93°C.
Preparation of the compound 10c
Isobutyl chloroformate (6.84 mmol) was added to a solu-
tion of 12 (6.84 mmol) and NMM (7.18 mmol) in an-
hydrous THF (15 mL) at −20°C. The resulting mixture
was agitated for 30 min and the amine (1.05 mmol) was
then added drop-wise. The mixture was then stirred for1 h at −10°C followed by 12 h at room temperature. The
reaction mixture was distilled in vacuo and the resulting
solid dissolved in DCM (40 mL), before being washed
with brine, dried over MgSO4, and evaporated in vacuo
to give the crude product, which was purified by flash
chromatography eluting with petroleum ether-EtOAc (1:
3) to give compound 10c as a white solid; Yield: 73%, m.
p.: 102–104°C; 1H NMR (400 MHz, CDCl3) δ 2.47 (t,
2H, J = 7.6 Hz, CH2CH2), 2.90 (t, 2H, J = 7.6 Hz,
CH2CH2), 3.21–3.28 (m, 1H, CHCH2), 3.58–3.64(m, 1H,
CHCH2), 3.85(s, 3H, p-ArOCH3), 3.86 (s, 3H, o-
ArOCH3), 4.75(dd, 1H, J = 3.5 Hz, CH2CH), 5.81(br, 1H,
CONH), 6.71–6.80 (m, 3H, Ar-H), 7.21 (d, 2H, J =
8.4 Hz, Ar-H), 7.29 (d, 2H, J = 8.4 Hz, Ar-H).
Preparation of the compound 13
Compound 13 was prepared according to the same pro-
cedure as compound 7.
13a: R2 = H, R1 = Me, R3 = benzyl, white solid, m.p.:
131–132°C; Yield: 70%; 1H NMR (400 MHz, CDCl3) δ
2.44 (t, 2H, J = 7.2 Hz, CH2CH2), 2.90 (t, 2H, J = 7.2 Hz,
CH2CH2), 3.22–3.27 (m, 1H, CH2CH), 3.73–3.78 (m,
1H, CH2CH), 3.86 (s, 3H, o-ArOCH3), 3.88 (s, 3H, p-
ArOCH3), 4.24 (d, 1H, J = 11.2 Hz, PhCH2), 4.42 (dd,
1H, J = 4.0 Hz, CH2CH), 4.50 (d, 1H, J = 11.2 Hz,
PhCH2), 5.78 (br, 1H, CONH), 6.75–6.80 (m, 3H, Ar-H),
7.31–7.42(m, 10H, Ar-H); 13C NMR (101 MHz, CDCl3)
δ 172.0, 148.9, 147.4, 139.2, 138.1, 133.5, 128.7, 128.5,
128.3, 127.9, 126.8, 120.1, 111.7, 111.3, 80.2, 70.7, 55.9,
55.8, 45.6, 38.8, 31.3; HRMS (ESI) (M+Na)+ Calcd for
C26H29NO4Na
+ 442.1983, found 442.1989.
13b: R2 = p-Cl, R1 = Me, R3 = propynyl, white solid,
m.p.: 78–80°C; Yield: 71%; 1H NMR (400 MHz, CDCl3)
δ 2.44 (s, 1H, C≡CH), 2.50 (t, 2H, J = 7.6 Hz, CH2CH2),.
2.94 (t, 2H, J = 7.6 Hz, CH2CH2), 3.13–3.18 (m, 1H,
CH2CH), 3.71–3.78 (m, 1H, CH2CH), 3.84 (s, 1H,
C≡CHCH2), 3.88 (s, 3H, o-ArOCH3), 3.89 (s, 3H, p-
ArOCH3), 4.12 (dd, 1H, J = 15.6 Hz, J = 2.0 Hz,
C≡CHCH2), 4.54 (dd, 1H, J = 9.2 Hz, J = 3.6 Hz,
CH2CHAr), 5.86 (br, 1H, CONH), 6.76–6.83 (m, 3H, Ar-
H), 7.24 (d, 2H, J = 8.0 Hz, Ar-H), 7.35 (d, 2H, J =
8.0 Hz, Ar-H); HRMS (ESI) (M+Na)+ Calcd for
C22H24ClNO4Na
+ 424.1292, found 424.1290.
13c: R2 = p-Cl, R1 = Me, R3 = benzyl, white solid, m.
p.: 91°C; Yield: 65%; 1H NMR (400 MHz, CDCl3) δ 2.41
(t, 2H, J = 7.6 Hz, CH2CH2), 2.87 (t, 2H, CH2CH2),
3.13–3.21 (m, 1H, CH2CH), 3.65–3.72 (m, 1H, CH2CH),
3.84 (s, 3H, o-ArOCH3), 3.86 (s, 3H, p-ArOCH3), 4.21
(d, 1H, J = 11.6 Hz, PhCH2), 4.38 (dd, 1H, J = 4.0 Hz,
CH2CH), 4.45 (d, 1H, J = 11.6 Hz, PhCH2), 5.74 (br, 1H,
CONH), 6.72–6.79 (m, 3H, Ar-H), 6.92–6.94 (m, 2H,
Ar-H), 7.25–7.36 (m, 7H, Ar-H); 13C NMR (101 MHz,
CDCl3) δ 172.0, 148.9, 147.5, 137.8, 134.0, 133.4, 128.9,
128.6, 128.1, 128.0, 127.9, 120.1, 111.7, 111.3, 79.5, 70.8,
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for C26H29NO4Na
+ 476.1590, found 476.1599.
13d: R2 = p-Cl, R1 = n-Pr, R3 = Me, white solid; m.p.:
92–93°C; Yield: 65%; 1H NMR (400 MHz, CDCl3) δ 1.01
(t, 3H, J = 6.8Hz, CH2CH3), 1.80–1.87 (m, 2H,
CH3CH2), 2.47 (t, 2H, J = 6.8 Hz, COCH2), 2.90 (t, 2H, J
= 6.8 Hz, Ar–CH2), 3.08-3.17 (m, 4H, CHOCH3
+NHCH2), 3.61–3.66 (m, 1H, NHCH2), 3.85 (s, 3H,
ArOCH3), 3.94 (t, 2H, J = 6.4 Hz, ArOCH2), 4.13 (dd,
1H, J = 5.2 Hz, J = 7.6 Hz, OCH), 5.81 (br, 1H, CONH),
6.70–6.84 (m, 3H, Ar-H), 7.17–7.33 (m, 4H, Ar-H); 13C
NMR (101 MHz, CDCl3) δ 172.1, 149.3, 147.0, 137.6,
133.9, 133.4, 128.8, 128.0, 120.2, 113.1, 112.2, 81.7, 70.6,
56.8, 56.0, 45.5, 38.7, 31.3, 22.5, 10.5; HRMS (ESI) (M+H)
+ Calcd for C22H28ClNO4H
+ 406.1770, found 406.1780.
13e: R2 = p-Cl, R1 = n-Pr, R3 = Et, white solid; m.p.:
69–70°C; Yield: 59%;1H NMR (400 MHz, CDCl3) δ 1.01
(t, 3H, J = 5.2Hz, CHOCH2CH3), 1.13 (t, 3H, J = 5.2Hz,
ArOCH2CH2CH3), 1.78–1.92 (m, 2H, ArOCH2CH2),
2.48 (t, 2H, J = 6.0 Hz, COCH2), 2.90 (t, 2H, J = 6.0 Hz,
Ar-CH2), 3.08–3.68 (m, 3H, CHOCH2+NHCH2), 3.60–
3.64 (m, 1H, NHCH2), 3.84 (s, 3H, ArOCH3), 3.93 (t,
2H, J = 6.4 Hz, ArOCH2), 4.23 (dd, 1H, J = 2.8 Hz, J =
4.8 Hz, OCH), 5.82 (br, 1H, CONH), 6.68–6.84 (m, 3H,
Ar-H), 7.18–7.31 (m, 4H, Ar-H); 13C NMR (101 MHz,
CDCl3) δ 172.1, 149.3, 147.0, 138.3, 133.7, 133.4, 128.7,
127.9, 120.2, 113.0, 112.2, 79.8, 70.6, 64.5, 56.0, 45.5,
38.7, 31.3, 22.5, 15.2, 10.5; HRMS (ESI) (M+H)+ Calcd
for C23H30ClNO4H
+ 420.1933, found 420.1936.
13f: R2 = p-Cl, R1 = n-Pr, R3 = propynyl, white solid;
m.p.: 61–62°C; Yield: 66%; 1H NMR (400 MHz, CDCl3)
δ 1.02 (t, 3H, J = 7.2 Hz, CH2CH3), 1.80–1.87 (m, 2H,
CH3CH2), 2.41 (s, 1H, C≡CH), 2.48 (t, 2H, J = 7.2 Hz,
COCH2), 2.90 (t, 2H, J = 7.6 Hz, Ar-CH2), 3.10–3.16 (m,
1H, NHCH2), 3.69–3.74 (m, 1H, NHCH2), 3.81–3.85 (m,
4H, OCH3 + CHOCH2), 3.94 (t, 2H, J = 6.8 Hz,
ArOCH2), 4.10 (d, 1H, J = 16.0 Hz, CHOCH2), 4.51 (dd,
1H, J = 3.6 Hz, J = 8.4 Hz, OCH), 5.87 (br, 1H, NH),
6.71–6.84 (m, 3H, Ar-H), 7.21–7.34 (m, 4H, Ar-H); 13C
NMR (101 MHz, CDCl3) δ 172.1, 149.6, 145.2, 136.6,
135.0, 134.3, 128.9, 128.2, 120.1, 114.6, 112.2, 79.3, 78.9,
78.8, 75.8, 74.9, 56.8, 56.1, 55.9, 45.2, 38.5, 31.3. HRMS
(ESI) (M+H)+ Calcd for C24H28ClNO4H
+ 430.1781,
found 430.1780.
13g: R2 = p-Cl, R1 = n-Pr, R3 = allyl, white solid; m.p.:
56–58°C; Yield: 72%; 1H NMR (400 MHz, CDCl3) δ 1.02
(t, 3H, J = 7.2 Hz, CH2CH3), 1.80–1.87 (m, 2H,
CH3CH2), 2.47 (t, 2H, J = 6.8 Hz, COCH2), 2.89 (t, 2H, J
= 7.2 Hz, Ar-CH2), 3.13–3.17 (m, 1H, NHCH2), 3.63–
3.73 (m, 2H, NHCH2+ CHOCH2), 3.82–3.95 (m, 6H,
OCH3+ArOCH2+CHOCH2), 4.32 (dd, 1H, J = 2.8 Hz, J
= 6.0 Hz, OCH), 5.15–5.22 (m, 2H, CH=CH2), 5.81–5.85
(m, 2H, CH2=CH+NH), 6.70–6.84 (m, 3H, Ar-H), 7.18–
7.32 (m, 4H, Ar-H); 13C NMR (101 MHz, CDCl3) δ172.1, 149.3, 147.0, 137.9, 134.2, 133.9, 133.4, 128.8,
128.0, 120.2, 117.4, 113.1, 112.2, 79.3, 70.6, 69.8, 56.0,
45.5, 38.7, 31.3, 22.5, 10.5; HRMS (ESI) (M+H)+ Calcd
for C24H30ClNO4H
+ 432.1931, found 432.1936.
13h: R2 = p-Cl, R1 = n-Pr, R3 = benzyl, white solid; m.
p.: 79–81°C; Yield: 70%; 1H NMR (400 MHz, CDCl3) δ
1.02 (t, 3H, J = 7.2 Hz, CH2CH3), 1.80–1.87 (m, 2H,
CH3CH2), 2.47 (t, 2H, J = 6.8 Hz, COCH2), 2.89 (t, 2H, J
= 7.2 Hz, Ar-CH2), 3.13–3.17 (m, 1H, NHCH2), 3.63–
3.73 (m, 2H, NHCH2+CHOCH2), 3.82–3.95 (m, 6H,
OCH3+ArOCH2+CHOCH2), 4.32 (dd, 1H, J = 2.8 Hz, J
= 6.0 Hz, OCH), 5.15–5.22 (m, 2H, CH=CH2), 5.81–5.85
(m, 2H, CH2=CH+NH), 6.70–6.84 (m, 3H, Ar-H), 7.18–
7.32 (m, 4H, Ar-H); 13C NMR (101 MHz, CDCl3) δ
172.1, 149.4, 147.0, 137.8, 137.8, 134.0, 133.4, 128.9,
128.6, 128.2, 127.98, 127.9, 120.2, 113.1, 112.2, 79.5,
70.9, 70.6, 56.0, 45.5, 38.7, 31.3, 22.5, 10.5; HRMS (ESI)
(M+H)+ Calcd. for C28H32ClNO4H
+ 482.2092, found
482.2093.
13i: R2 = p-Cl, R1 = propynyl, R3 = propynyl, white
solid; m.p.: 89–90°C; Yield: 41%; 1H NMR (400 MHz,
CDCl3) δ 2.41–2.48 (m, 4H, COCH2+ArOCH2C≡CH
+CHOCH2C≡CH), 2.91 (t, 2H, J = 6.8Hz, Ar-CH2),
3.10–3.16 (m, 1H, NHCH2), 3.69–3.73 (m, 1H, NHCH2),
3.81–3.85 (m, 4H, ArOCH3+CHOCH2), 4.10 (d, 1H, J =
16.0Hz, CHOCH2), 4.51 (dd, 1H, J = 2.8Hz, J = 7.6Hz,
OCH), 4.73 (s, 2H, ArOCH2), 5.87 (br, 1H, NH), 6.73–
6.79 (m, 2H, Ar-H), 6.95 (d, 1H, J = 8.0Hz, Ar-H), 7.21–
7.33 (m, 4H, Ar-H); 13C NMR (101 MHz, CDCl3) δ
172.2, 149.3, 147.0, 136.7, 134.3, 133.4, 128.9, 128.2,
120.2, 113.1, 112.2, 79.3, 78.9, 74.9, 70.6, 56.0, 56.0, 45.2,
38.7, 31.3, 22.5, 10.5; HRMS (ESI) (M+H)+ Calcd for
C24H24ClNO4H
+ 426.1458, found 426.1467.
Biological assay
Antiviral biological assay
Purification of tobacco mosaic virus
Using Gooding’s method [27], the upper leaves of Nicotiana
tabacum L. inoculated with TMV were selected and ground
in a phosphate buffer before being filtered through a
double-layer pledget. The filtrate was centrifuged at
10000 g, treated twice with PEG, and centrifuged again.
The entire experiment was conducted at 4°C. The absorb-
ance values were estimated at 260 nm using an ultraviolet
spectrophotometer according to the following equation:
Virus concentration ¼ A260  dilution rationð Þ=E0:1%;260nm1cm
Protective effect of compounds against TMV in vivo
The compound solution was smeared on the left side of
growing N. tabacum L. leaves of the same ages, whereas
the solvent alone was used as a control on the right side.
The leaves were then inoculated with the virus after
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× 10-3 mg/mL to inoculate the leaves, which were previ-
ously scattered with silicon carbide. The leaves were
then washed with water and rubbed softly once or twice
along the nervature. The local lesion numbers appearing
3–4 days after inoculation were counted. The experi-
ment was performed in triplicate for each compound.Curative effect of compounds against TMV in vivo
Growing leaves of N. tabacum L. of the same ages were
selected. The tobacco mosaic virus (concentration of 6 ×
10-3 mg/mL) was dipped and inoculated onto the whole
leaves. The leaves were then washed with water and
dried. The compound solution was then smeared onto
the left sides of the leaves, whereas the solvent alone
was used as a control and smeared on the right side.
The local lesion numbers were then counted and
recorded 3–4 days after the inoculation [25]. The experi-
ment was performed in triplicate for each compound.
The in vivo inhibition rate of each compound was then
calculated according to the following formula:Inhibition rate %ð Þ
¼ av local lesion no:of control av local lesion no:of drug treatedð Þ=av local lesion no:of control½   100%Where “av” means average, and the controls were not
treated with any test compounds.
Larvicidal activity against mosquitoes
A stock solution of each compound was prepared at
1000 μg/mL using acetone as a solvent. Each compound
solution in acetone was then suspended in distilled water
with Tween-80 (0.001%). Distilled water mixed with
Tween-80 was used as a control. Batches of 10 fourth-
stage larvae of C. pipiens pallens were pipetted into beakers
(100 mL) containing each of test solution (40 mL). Each
test compound was evaluated at a 2 μg/mL level in distilled
water. Observations of larval mortality were recorded after
24 h. The larvae were considered dead if appendages did
not move when prodded with a needle.
Rectified mortality %ð Þ ¼ A1 A2ð Þ= 100 A2ð Þ
 100
where Al (%) is the mortality in the treatment group, and
A2 (%) is the mortality in the control group.
Insecticidal activity against bean aphids (Aphis fabae
Scopoli)
Bean aphids were dipped according to a slightly modified
FAO (Food and Agriculture Organization) dip test [28].
The tender shoots of soybean with 40–60 healthy apterous
adult aphids were dipped in the diluted compoundsolutions for 5 s, and the superfluous fluid was removed
and placed in a conditioned room. Mortality was calculated
48 h after treatment. Each treatment was performed in
triplicate. Chlorfenapyr was used as a standard. The data
for the mortality-regression lines of the compounds were
subjected to probit analysis by Finney’s method.Acaricidal activity against two spot spider mite
(T. cinnabarinus boisduval)
Thirty female adult spider mites were fixed dorsally to a
strip of double-sided tape attached to the slide using a
small brush. The slide was immersed and shaken for 10 s
in a diluted solution of the test compound. After the ex-
cessive solution was removed, the treated slides with the
mites were kept at 25°C (± 2°C) in a Petri dish with moist
filter paper. The number of the dead mites was recorded
24 h after treatment. Each treatment was performed in
triplicate, with each experiment involving 30 adult mites
[29]. Chlorfenapyr was used as the standard. The data for
the mortality-regression lines of the compounds were
subjected to probit analysis by Finney’s method.Conclusion
In conclusion, two series of ferulic acid derivatives have
been synthesized efficiently. The bioassay showed title
compounds not only inhibit the plant viral infection, but
also prevented the spread of plant virus by insect vectors.
Compounds 7a, 7b and 7d in particular exhibited good
levels of antiviral and insecticidal activity. These findings
therefore demonstrate that the ferulic acid amides repre-
sent a new template for future antiviral studies.
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